Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca moves manufacturing to Ireland due to Britain’s tax regime

February 10, 2023
Medical Communications

Big pharma giant, AstraZeneca, has announced that its plans to open a new facility in northwest England have now changed, …

News

SynaptixBio secures FDA Rare Paediatric Disease designation to develop treatments for TUBB4a leukodystrophy

February 10, 2023
Research and Development

SynaptixBio, a UK-based biotech firm, has been granted FDA Rare Paediatric Disease (RPD) designation – an accolade which encourages the …

News

AbbVie expects 37% decline in Humira sales following new biosimilars hitting the US market

February 10, 2023
Sales and Marketing

AbbVie Inc has announced that it expects to see a 37% decline in sales of its flagship rheumatoid arthritis drug …

News

FDA grants full approval to GSK for mismatch repair-deficient endometrial cancer treatment

February 10, 2023
Medical Communications

GSK announced that its treatment for recurrent or advanced mismatch repair-deficient (dMMR) endometrial cancer has been granted full approval by …

News

RQ Bio Strengthens Board with Industry-leading Infectious Disease Experts Joining as Non-Executive Directors

February 9, 2023
Business Services

LONDON, UK, 9 February 2023 — RQ Bio is scaling up at speed, with the appointment of Non-Executive Directors, Dr …

Appointment

Stand Up To Cancer announces four teams dedicated to increasing diversity in clinical trials

February 9, 2023
Medical Communications

Stand Up To Cancer (SU2C) has announced four teams that will focus on increasing diversity in early phase cancer clinical …

News

FDA grants RMAT designation for Mesoblast’s chronic low back pain treatment

February 9, 2023
Medical Communications

Mesoblast Ltd, an Australian regenerative medicine company leading in allogeneic cellular medicines for inflammatory diseases, announced that its treatment for …

News

FDA approves Regeneron’s Eylea for the treatment of retinopathy of prematurity in infants

February 9, 2023
Research and Development

The FDA has approved Regeneron Pharmaceuticals’ Eylea (aflibercept) injection for the treatment of retinopathy of prematurity (ROP) in preterm infants. …

News

Garuda Therapeutics closes series B funding with $62m

February 9, 2023
Sales and Marketing

Cambridge-based Garuda Therapeutics announced it closed a $62m series B funding round to support its off-the-shelf, self-renewing blood stem cell …

News

The First Women in Leadership Network to Support Diversity, Equality and Inclusion across the Life Sciences Industry launched in Denmark

February 9, 2023
Business Services

9 February 2023, Denmark: Women in Life Science Denmark (WiLD), an inspiring and science-centric not-for-profit network for women in senior …

News
Press release

Redx Provides Progress Update on RXC007 Clinical Programme

February 9, 2023
Business Services

Alderley Park, UK, 9 February 2023 Redx (AIM:REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, …

News
Press release

Sequana Medical announces 2022 Full Year Results and 2023 Outlook

February 9, 2023
Business Services

Ghent, Belgium – 09 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical”), a pioneer …

News
Press release

Availability of Sanofi’s Nexviadyme®▼(avalglucosidase alfa) provides NHS with new treatment for Pompe disease

February 8, 2023
Business Services

READING, ENGLAND – Wednesday 8th February 2023. Sanofi announced today that healthcare specialists and patients living with Pompe disease will …

News
Press release

Scottish biotech aims to cure common cold

February 8, 2023
Medical Communications

Scottish biotech company ScotBio has announced that it has seen “promising initial results” from its attempts to extract a cure …

News

Johnson & Johnson’s Ethicon undertakes first robot-assisted kidney stone removal

February 8, 2023
Research and Development

Johnson & Johnson (J&J) medtech company, Ethicon, has announced its first robotic-assisted kidney stone removal using its Monarch platform. The …

News

US Department of Justice asks Third Circuit to reinstate conspiracy charges again KVK

February 8, 2023
Manufacturing and Production

The US Department of Justice (DoJ) encouraged the Third Circuit to reinstate ‘conspiracy to defraud’ charges against Philadelphia-based generic drug …

News

Sandoz files Amgen biosimilar drug for osteoporosis

February 8, 2023
Research and Development

Switzerland-based Sandoz has filed a proposed biosimilar of Amgen’s osteoporosis drug Prolia/Xgeva with the FDA. According to Sandoz, over 10 …

News

Cell and Gene Therapy Catapult to play significant role in establishing one of the largest life sciences campuses in Europe

February 8, 2023
Business Services

London, 8th February 2023: The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in …

News
Press release

Sequana Medical announces the successful completion of pre-clinical studies with its second-generation DSR product for congestive heart failure

February 8, 2023
Business Services

Ghent, Belgium – 08 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana

News
Press release

AstraZeneca’s Forxiga approved in EU for chronic heart failure

February 7, 2023
Medical Communications

AstraZeneca has announced that its drug, Forxiga, has been approved in the EU for the treatment of symptomatic chronic heart …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026